INTRODUCTION Gastrointestinal stromal tumors (GIST) are the most frequent mesenchymal tumors of the digestive tract. Extraintestinal locations (EGIST) have been described showing similar pattern of immunohistochemical markers than GIST. Inhibitors of tyrosine kinases such as Imatinib or Sunitinib...
Enlace original:
https://repositorio.uc.cl/handle/11534/27471https://repositorio.uc.cl/handle/11534/27471
Quezada, N.
,
Acevedo, F.
,
Marambio, A.
,
León, F.
,
Galindo, H.
,
Roa, J. C.
,
Jarufe, N.
,
[Complete pathological response to Imatinib mesylate in an extraintestinal gastrointestinal stromal tumor]
,
Complete pathological response to Imatinib mesylate in an extraintestinal gastrointestinal stromal tumor
